Inventor

TIAN YE EDWARD

US19 patents

⚠️ This page may combine multiple inventors who share the name “TIAN YE EDWARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TIAN YE EDWARD

IMPACT THERAPEUTICS INC

Substituted fused heteroaromatic compounds as kinase inhibitors and the use thereof

1-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof

1-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof

1-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs and the use thereof

N-(3-heteroarylaryl)-4-arylarylcarboxamides and analogs as hedgehog pathway inhibitors and use thereof

8,9-dihydroimidazo[1,2-a]pyrimido[5,4-e]pyrimidin-5(6H)-ones

1-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof

IMPACT THERAPEUTICS SHANGHAI INC

8,9-dihydroimidazo[1,2-a]pyrimido[5,4-e]pyrimidin-5(6H)-ones

Imidazo[1,2-b]pyrimido[4,5-d]pyridazin-5(6H)-ones and the use thereof

3,5-disubstituted pyrazole compounds as kinase inhibitors and uses thereof

Substituted fused heteroaromatic bicyclic compounds as kinase inhibitors and the use thereof

Substituted fused heteroaromatic tricyclic compounds as kinase inhibitors and the use thereof

TRANSTECH PHARMA INC

RAGE fusion proteins, formulations, and methods of use thereof

Rage fusion proteins

Nucleic acid molecules encoding rage fusion proteins

MJALLI ADNAN M M

Rage fusion proteins and methods of use

CAI SUI XIONG

1-(Arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof

PFIZER

VEGF responsive cell-based assay for determining VEGF bioactivity

CAI SUIXIONG

3-aryl-6-aryl-[1,2,4]triazolo[4,3-α]pyridines as inhibitors of cell proliferation and the use thereof